MDG1:FRA
MediGene AG
ā¬0.017
arrow_upward
+3.61%(+0.00060) 1D
Jun 30, 9:00:00āÆPM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
News stories
From web sources and news partners
TradingView
·
1 day ago
H&S in a Falling Channel, Short Toward 7,000 for CAPITALCOM:SPX500 by Audacity618
BigGo Finance
·
6 hours ago
Global AI and Semiconductor Stocks Plunge; S&P 500 Tumbles 4.4% in a Single Day as Markets Watch Whether Three Central Banks Will Raise Rates in December
FXLeaders
·
3 hours ago
Dow Futures Eye 52,800 Target as Inflation Data and Treasury Yield Pullback Signal Rally
Briefs Finance
·
16 hours ago
Inflation Mentions Hit S&P 500 Earnings Calls Peak
Profile
Medigene AG is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development. Wikipedia